A TGF-βR/IL-2R immunomodulatory fusion protein transforms immunosuppression into T cell activation to enhance adoptive T cell therapy

Journal:
Proceedings of the National Academy of Sciences of the United States of America
Published:
DOI:
10.1073/pnas.2516951122
Affiliations:
7
Authors:
8
Go to article
Institutions Authors Share
Fred Hutchinson Cancer Center, United States of America (USA)
5.666667
 0.71
University Hospital of Lausanne (CHUV), UNIL, Switzerland
1.000000
 0.13
University of Washington (UW), United States of America (USA)
0.666667
 0.08
Wellcome Trust Genome Campus, United Kingdom (UK)
0.333333
 0.04
Wellcome Trust - MRC Cambridge Stem Cell Institute, University of Cambridge, United Kingdom (UK)
0.333333
 0.04
Interested in Oncology and Carcinogenesis?